Cabaletta Bio Announces Pricing of $150 Million Underwritten Offering

Stock Information for Cabaletta Bio Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Cabaletta Bio Inc.

Cabaletta Bio and Cellares Announce 10-Year Commercial Supply Agreement for Rese-cel
Cabaletta Bio Announces Multiple Upcoming Presentations, Including Data on Rese-cel without Preconditioning and Rese-cel with Automated Manufacturing, at the ASGCT 2026 Annual Meeting
Cabaletta Bio Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
Cabaletta Bio to Participate in the TD Cowen 46th Annual Health Care Conference
Cabaletta Bio to Participate in the Guggenheim Emerging Outlook: Biotech Summit 2026
Cabaletta Bio Announces 2026 Strategic Priorities
Cabaletta Bio Reports Third Quarter 2025 Financial Results and Provides Business Update
Cabaletta Bio to Participate in Upcoming Investor Conferences in November and December

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.